Snowball logo
logo
GMED_logo

Globus Medical, Inc

$81.83+$0.42ย  (0.52%)
Estimate
P/E
21
EPS
3.9
Beta
0.959
Growth
Revenue, YoY
5.94%
Net income, YoY
-25.28%
FCF, YoY
571.3%
Forecast
P/E (FWD)
15.2
EPS (FWD)
5.398
About the company
Ticker
GMED
ISIN
US3795772082
Country
United States of America
Sector (GICS)
Healthcare
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Frequently asked questions

What sector does Globus Medical, Inc (GMED) operate in?

Globus Medical, Inc belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Globus Medical, Inc (GMED) current stock price?

As of the latest data, Globus Medical, Inc stock price is $81.83, with a previous close of $81.41. Globus Medical, Inc gained $0.42 in the last trading session, representing a 0.52% increase.

What is Globus Medical, Inc (GMED) current market capitalization?

Globus Medical, Inc market cap is approximately 9.15 billion.

What is Globus Medical, Inc (GMED) Earnings Per Share (EPS)?

The trailing EPS is $3.90, and the forward EPS is $5.40.

What is Globus Medical, Inc (GMED) Price-to-Earnings (P/E) ratio?

Globus Medical, Inc current P/E ratio is 20.98, with a forward P/E of 15.16.

What is Globus Medical, Inc (GMED) EBITDA?

Globus Medical, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 259.32 million.

Does Globus Medical, Inc (GMED) pay dividends?

No. Globus Medical, Inc does not pay a dividend.

How did Globus Medical, Inc (GMED) perform in its most recent earnings report?

In the last report (June 30, 2026), Globus Medical, Inc posted an EPS surprise of 19.64% and a revenue surprise of 0.85%.

When is Globus Medical, Inc (GMED) next earnings report?

Globus Medical, Inc is expected to release its next earnings report on September 30, 2026.

What is Globus Medical, Inc (GMED) beta (volatility) score?

Globus Medical, Inc has a beta of 0.959, meaning its volatility is roughly in line with the market.